Effect of Cardiac Resynchronization on Myocardial Efficiency and Regional Oxidative MetabolismHeikki Ukkonen, Anthony Tang, Rob Beanlands et al.|Circulation|2003Cited by 205
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trialPK Judge, A. Q. Adeleke, Natalie Staplin et al.|The Lancet Diabetes & Endocrinology|2023Cited by 107
Plasma Proteomics to Identify Drug Targets for Ischemic Heart DiseaseMohsen Mazidi, Simon Gilbert, Pang Yao et al.|Journal of the American College of Cardiology|2023Cited by 39
<i>PCSK9</i> genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populationsMichael V. Holmes, Hubert Lam, Christiana Kartsonaki et al.|European Journal of Preventive Cardiology|2024Cited by 10